再分散性高药负荷无形配方的设计:离子对非离子表面活性剂对加工和性能的影响
Mengqi Yu1, Hardeep S Oberoi1, Hitesh S Purohit1
1Research & Development, AbbVie Inc., North Chicago, Illinois 60064, United States.
Molecular pharmaceutics
|October 25, 2023
概括
使用维生素ETPGS,可以制备具有高药物负载 (>90%) 的工程无形纳米粒子 (ANP). 这些ANP保持生物可用性,同时减少对溶解不良药物的聚合物需求.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 无形固体分散 (ASD) 增强了口服药物的生物可用性,但通常需要高的聚合物含量 (<25%的药物负载).
- 在ASD的局部纳米粒子形成驱动超和,以改善药物吸收.
- 直接设计的无形纳米粒子 (ANP) 提供了一种减少聚合物使用的策略.
研究的目的:
- 用维生素ETPGS (TPGS) 作为稳定剂制备和描述高药载无形纳米粒子 (ANPs).
- 将TPGS稳定ANP与使用阳离子表面活性剂 (二硫酸盐) 制备的ANP进行比较.
- 评估表面活性剂选择对ANP属性和再分散行为的影响.
主要方法:
- 溶剂/抗溶剂纳米沉,有机溶剂去除和喷雾干燥用于ANP制备.
- 动态光散射,过剂强度测定,扫描电子显微镜和差分扫描热量计被用于表征.
- 模型化合物ABT-530用于用TPGS准备ANP.
主要成果:
- 使用TPGS成功制备了高药载荷ANP (<300nm).
- 描述揭示了纳米粒子表面特性受表面活性剂影响的差异 (TPGS与阳离子).
- 稳定剂的选择显著影响ANP的行为和再分散.
结论:
- 维生素ETPGS是一种有效的非离子表面活性剂,用于制备高药载荷无形纳米粒子.
- 了解表面活性剂的影响对于设计有效的高药载荷无形配方至关重要.
- 优化稳定剂可以导致减少聚合物数量,而不会影响生物可用性.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
136
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
136
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
314
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
314
Factors Affecting Dissolution: Particle Size and Effective Surface Area
864
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
864
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
209
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
209
Factors Influencing Drug Absorption: Physicochemical Parameters
303
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
303
Factors Influencing Drug Absorption: Drug Dissolution
531
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
531


